Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for RSCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 42.89%
March 31, 2026 34.70%
December 31, 2025 35.67%
September 30, 2025 34.61%
June 30, 2025 27.44%
March 31, 2025 38.59%
December 31, 2024 16.88%
September 30, 2024 36.95%
June 30, 2024 35.67%
March 31, 2024 23.13%
December 31, 2023 -50.11%
September 30, 2023 33.14%
June 30, 2023 -75.56%
March 31, 2023 -14.43%
December 31, 2022 12.01%
September 30, 2022 -9.32%
June 30, 2022 36.03%
March 31, 2022 46.31%
December 31, 2021 46.76%
September 30, 2021 45.68%
June 30, 2021 46.08%
March 31, 2021 50.14%
December 31, 2020 60.85%
September 30, 2020 45.94%
June 30, 2020 33.45%
Date Value
March 31, 2020 40.29%
December 31, 2019 14.42%
September 30, 2019 41.35%
June 30, 2019 23.44%
March 31, 2019 35.03%
December 31, 2018 32.81%
September 30, 2018 22.16%
June 30, 2018 16.25%
March 31, 2018 47.83%
December 31, 2017 -158.4%
September 30, 2017 41.61%
June 30, 2017 24.61%
March 31, 2017 23.68%
December 31, 2016 -83.88%
September 30, 2016 17.12%
June 30, 2016 45.61%
March 31, 2016 42.67%
December 31, 2015 -76.48%
September 30, 2015 19.76%
June 30, 2015 18.48%
March 31, 2015 28.00%
December 31, 2014 -64.84%
September 30, 2014 23.67%
June 30, 2014 28.82%
March 31, 2014 34.77%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
West Pharmaceutical Services, Inc. 37.83%
Agilent Technologies, Inc. 54.01%
Anika Therapeutics, Inc. 65.15%
Bio-Rad Laboratories, Inc. 53.12%
Bruker Corp. 49.65%

Gross Profit Margin (Quarterly) Related Metrics